 |
|
|
| |
Glasgow: Patient Preferences for Characteristics of Antiretroviral Therapies: Results From 5 European Countries
|
| |
| |
Reported by Jules Levin
HIV Drug Therapy Glasgow; November 2-6, 2014; Glasgow, UK
Gazzard B,1 Ali S,2 Mühlbacher A,3 Ghafouri N,4 Maggiolo F,5 Golics C,6 Nozza S,7 Fuster MJ,8 Antela A,9 Parienti JJ,10 Dang N,11 Bregigeon SR,12 Benzie A,13 Murray M11
1Chelsea and Westminster Hospital, London, England; 2Health Research Solutions Limited, London, UK; 3IGM Institut Gesundheitsökonomie und Medizinmanagement, Hochschule Neubrandenburg, Neubrandenburg, Germany; 4ViiV Healthcare GmbH, Munich, Germany; 5Ospedali Riuniti di Bergamo, Bergamo, Italy; 6ICON Patient Reported Outcomes, Oxford, UK; 7San Raffaele Scientific Institute, Milano, Italy; 8SEISIDA, Madrid, Spain; 9Hospital Clínico Universitario, Santiago de Compostela, Spain; 10Infectious Diseases Department, University Hospital, Caen, France; 11ViiV Healthcare, London, UK; 12APHM, CHU Sainte-Marguerite, Service Immuno-Hématologie Clinique, Marseille, France; 13GlaxoSmithKline, Stockley Park, London, UK
|
| |
|
|
|
|
|
